CHR-3996 (Nanatinostat)

Name: CHR-3996 (Nanatinostat); MyBioSource
Brand: MyBioSource
SKU: MBS3601049
Price: 425 USD
Availability: InStock
Rating: 5 (10 reviews)

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS3601049

CHR-3996 (Nanatinostat, VRx-3996, CHR3996, Tractinostat) is a potent, class I-selective, orally active HDAC inhibitor with IC50 of 3-7 nM for HDAC1/2/3. More details

$425 / 5 mg +1 FREE 8GB USB

Product Documentation

Sample Manual Insert View PDF

Testing Data View PDF

Certificate of Analysis (COA) View PDF

QC Report View PDF

Material Safety Data Sheet View PDF

Technical Datasheet View PDF

Protocol View PDF

Product Overview

Online Datasheet in PDF

Product Name

CHR-3996, Biochemical

Full Product Name

CHR-3996

Product Synonym Names

Nanatinostat; CHR3996; VRx-3996; Tractinostat

Purity/Purification

>98% (HPLC)

Preparation and Storage

Store at -20 degree C
Stability: >=2 years
Shipping: Ice Pack

Molecular Weight

394.41

Target

HDAC

Receptor

HDAC

Chemical Name

2-[(1R, 5S, 6s)-6-{[(6-fluoroquinolin-2-yl)methyl]amino}-3-azabicyclo[3.1.0]hexan-3-yl]-N-hydroxypyrimidine-5-carboxamide

SMILES

O=C(C1=CN=C(N2C[C@]3([H])[C@@H](NCC4=NC5=CC=C(F)C=C5C=C4)[C@]3([H])C2)N=C1)NO

Molecular Formula

C20H19FN6O2

CAS Number

1256448-47-1

Product Categories/Family for CHR-3996 biochemical

Blood cancer; Cell Cycle/DNA Damage; Cancer

Product References and Citations for CHR-3996 biochemical

1. Moffat D, J Med Chem. 2010 Dec 23; 53 (24):8663-78.
2. Banerji U, et al. Clin Cancer Res. 2012 May 1; 18 (9):2687-94.
3. Smith EM, et al. Oncotarget. 2015 Jul 10; 6 (19):17314-27.

Other Notes

Small volumes of CHR-3996 biochemical vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for CHR-3996 purchase

MBS3601049 is a biochemical targeting CHR-3996.